These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2882409)

  • 21. Inhibition of Bordetella pertussis and Bacillus anthracis adenylyl cyclases by polyadenylate and "P"-site agonists.
    Johnson RA; Shoshani I
    J Biol Chem; 1990 Nov; 265(31):19035-9. PubMed ID: 2121733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metabolism of exogenously supplied nucleotides by Escherichia coli.
    LICHTENSTEIN J; BARNER HD; COHEN SS
    J Biol Chem; 1960 Feb; 235():457-65. PubMed ID: 14416749
    [No Abstract]   [Full Text] [Related]  

  • 23. ALTERATIONS IN THE BIOLOGICAL ACTIVITY OF PROTECTIVE ANTIGEN OF BACILLUS ANTHRACIS TOXIN.
    MOLNAR DM; ALTENBERN RA
    Proc Soc Exp Biol Med; 1963 Nov; 114():294-7. PubMed ID: 14101169
    [No Abstract]   [Full Text] [Related]  

  • 24. Purification of the third factor of anthrax toxin.
    SMITH H; STANLEY JL
    J Gen Microbiol; 1962 Nov; 29():517-21. PubMed ID: 13989434
    [No Abstract]   [Full Text] [Related]  

  • 25. The three factors of anthrax toxin: their immunogenicity and lack of demonstrable enzymic activity.
    STANLEY JL; SMITH H
    J Gen Microbiol; 1963 May; 31():329-37. PubMed ID: 13983400
    [No Abstract]   [Full Text] [Related]  

  • 26. Large-scale production of protective antigen of Bacillus anthracis in anaerobic cultures.
    PUZISS M; MANNING LC; LYNCH JW; BARCLAYE ; ABELOW I; WRIGHT GG
    Appl Microbiol; 1963 Jul; 11(4):330-4. PubMed ID: 13972634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification of factor I and recognition of a third factor of the anthrax toxin.
    STANLEY JL; SMITH H
    J Gen Microbiol; 1961 Sep; 26():49-63. PubMed ID: 13916257
    [No Abstract]   [Full Text] [Related]  

  • 28. Production of toxin in vitro by Bacillus anthracis and its spearation into two components.
    THORNE CB; MOLNAR DM; STRANGE RE
    J Bacteriol; 1960 Mar; 79(3):450-5. PubMed ID: 13838209
    [No Abstract]   [Full Text] [Related]  

  • 29. Purification of factors I and II of the anthrax toxin produced in vivo.
    STANLEY JL; SARGEANT K; SMITH H
    J Gen Microbiol; 1960 Feb; 22():206-18. PubMed ID: 13833788
    [No Abstract]   [Full Text] [Related]  

  • 30. The chemical basis of the virulence of Bacillus anthracis. VII. Two components of the anthrax toxin: their relationship to known immunising aggressins.
    SMITH H; TEMPEST DW; STANLEY JL; HARRIS-SMITH PW; GALLOP RC
    Br J Exp Pathol; 1956 Jun; 37(3):263-71. PubMed ID: 13342351
    [No Abstract]   [Full Text] [Related]  

  • 31. The chemical basis of the virulence of Bacillus anthracis. V. The specific toxin produced by B. Anthracis in vivo.
    SMITH H; KEPPIE J; STANLEY JL
    Br J Exp Pathol; 1955 Oct; 36(5):460-72. PubMed ID: 13269658
    [No Abstract]   [Full Text] [Related]  

  • 32. Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein.
    Katada T; Ui M
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3129-33. PubMed ID: 6954463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ca2+ regulation of cyclic nucleotide metabolism.
    Keller CH; LaPorte DC; Toscano WA; Storm DR; Westcott KR
    Ann N Y Acad Sci; 1980; 356():205-19. PubMed ID: 6940496
    [No Abstract]   [Full Text] [Related]  

  • 34. Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eucaryotic cells.
    Leppla SH
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():189-98. PubMed ID: 6328915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bordetella adenylate cyclase toxin: entry of bacterial adenylate cyclase into mammalian cells.
    Confer DL; Slungaard AS; Graf E; Panter SS; Eaton JW
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():183-7. PubMed ID: 6328914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bordetella pertussis: multiple attacks on host cell cyclic AMP regulation.
    Wolff J; Cook GH; Goldhammer AR; Londos C; Hewlett EL
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():161-72. PubMed ID: 6328913
    [No Abstract]   [Full Text] [Related]  

  • 37. Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase.
    Sekura RD; Fish F; Manclark CR; Meade B; Zhang YL
    J Biol Chem; 1983 Dec; 258(23):14647-51. PubMed ID: 6315733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tn5-induced mutations affecting virulence factors of Bordetella pertussis.
    Weiss AA; Hewlett EL; Myers GA; Falkow S
    Infect Immun; 1983 Oct; 42(1):33-41. PubMed ID: 6311749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pertussis toxin substrate, the putative Ni component of adenylyl cyclases, is an alpha beta heterodimer regulated by guanine nucleotide and magnesium.
    Codina J; Hildebrandt J; Iyengar R; Birnbaumer L; Sekura RD; Manclark CR
    Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4276-80. PubMed ID: 6308612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bordetella pertussis toxins.
    Wardlaw AC; Parton R
    Pharmacol Ther; 1982; 19(1):1-53. PubMed ID: 6304790
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.